Form EFFECT BIOCRYST PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 9:00 A.M. |
| Form: | S-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioCryst Pharma (BCRX) PT Raised to $17 at Jefferies
- My Greek Charter Highlights the Best Luxury Yacht Charter Solution for Groups Over 12 in Greece
- Lowercarbon Capital Joins Focused Energy's Series A — the Largest Fully Secured Series A in Global Fusion
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
